Patrick Ma to represent Penn State on Big Ten cancer research committee
Dr. Patrick Ma, professor of medicine at Penn State College of Medicine and medical oncologist specializing in thoracic oncology at Penn State Cancer Institute, has been appointed to represent the Cancer Institute on the Big Ten Cancer Research Consortium (CRC) Steering Committee.
The committee’s members meet regularly to review activities of the consortium, decide matters of policy and determine the criteria for approving concepts for development with the consortium. One researcher from each Big Ten CRC member institution serves on the committee.
Ma is associate director for translational research and disease team leader of the multidisciplinary thoracic oncology team at Penn State Cancer Institute. He is also co-leader of the next generation therapies program. His research interests include small cell and non-small cell lung cancers and mesothelioma.
“I would like to thank Dr. Raymond Hohl, director of Penn State Cancer Institute, for recruiting me to the Institute and allowing me to serve in this role with the Big Ten Cancer Research Consortium,” Ma said. “I look forward to working closely with my consortium colleagues toward achieving our mission and goals. With a strong spirit of true collaboration, sharing resources and sharing credit, we will contribute to the consortium’s long-term success.”
Read the full announcement and more about Dr. Ma from the Big Ten Cancer Research Consortium
If you're having trouble accessing this content, or would like it in another format, please email Penn State Health Marketing & Communications.